Outcomes of Patients Who Had an Incomplete Colonoscopy After a Positive Fecal Immunological Test
NCT ID: NCT05172713
Last Updated: 2021-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-01-16
2022-04-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening
NCT05163236
Circulating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay.
NCT03981679
Colorectal Cancer Screening French Organizations for the Follow-up After Colonoscopy
NCT03383367
Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening
NCT04767568
Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers
NCT02557061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With incomplete colonoscopy performed in 2018 after a positive fecal immunological test as part of the DOCCR
* Patient whose follow-up has ended
* Patient living in the Grand-Est region and in the department of the site concerned
* Examination carried out by a gastroenterologist from the Grand-Est region
* Subject not having expressed, after information, his opposition to the reuse of his data for the purposes of this research
Exclusion Criteria
* Colonoscopy performed after a positive Hemoccult® test (screening technique older than the immunological test and different sensitivity / specificity)
* Colonoscopy performed before the fecal immunological test
* Gastroenterologist performing the examination practicing outside the Grand-Est region
* Subject not able to understand the objectives of this research
* Subject under judicial control
* Subject under tutorship or curatorship
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service Hépato-Gastroentérologie et Assistance Nutritive - Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.